Analysis of the F2LR3 (PAR4) Single Nucleotide Polymorphism (rs773902) in an Indigenous Australian Population
The F2RL3 gene encoding protease activated receptor 4 (PAR4) contains a single nucleotide variant, rs773902, that is functional. The resulting PAR4 variants, Thr120, and Ala120, are known to differently affect platelet reactivity to thrombin. Significant population differences in the frequency of th...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-04-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fgene.2020.00432/full |
id |
doaj-7750e3e3a71b4504a0c4bf25224be957 |
---|---|
record_format |
Article |
spelling |
doaj-7750e3e3a71b4504a0c4bf25224be9572020-11-25T02:15:57ZengFrontiers Media S.A.Frontiers in Genetics1664-80212020-04-011110.3389/fgene.2020.00432495300Analysis of the F2LR3 (PAR4) Single Nucleotide Polymorphism (rs773902) in an Indigenous Australian PopulationDian Ningtyas0Russell J. Thomson1Volga Tarlac2Shivashankar H. Nagaraj3Shivashankar H. Nagaraj4Wendy Hoy5John D. Mathews6John D. Mathews7Simon J. Foote8Elizabeth E. Gardiner9Justin R. Hamilton10Brendan J. McMorran11Department of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, AustraliaCentre for Research in Mathematics and Data Science, School of Computer, Data and Mathematical Sciences, Western Sydney University, Parramatta, NSW, AustraliaAustralian Center for Blood Diseases, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, AustraliaInstitute of Health and Biomedical Innovation, School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD, AustraliaTranslational Research Institute, Brisbane, QLD, AustraliaCentre for Chronic Disease, Faculty of Health, The University of Queensland, Brisbane, QLD, AustraliaCentre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, VIC, AustraliaMenzies School of Health Research, Darwin, NT, AustraliaDepartment of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, AustraliaDepartment of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, AustraliaAustralian Center for Blood Diseases, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, AustraliaDepartment of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, AustraliaThe F2RL3 gene encoding protease activated receptor 4 (PAR4) contains a single nucleotide variant, rs773902, that is functional. The resulting PAR4 variants, Thr120, and Ala120, are known to differently affect platelet reactivity to thrombin. Significant population differences in the frequency of the allele indicate it may be an important determinant in the ethnic differences that exist in thrombosis and hemostasis, and for patient outcomes to PAR antagonist anti-platelet therapies. Here we determined the frequency of rs773902 in an Indigenous Australian group comprising 467 individuals from the Tiwi Islands. These people experience high rates of renal disease that may be related to platelet and PAR4 function and are potential recipients of PAR-antagonist treatments. The rs773902 minor allele frequency (Thr120) in the Tiwi Islanders was 0.32, which is similar to European and Asian groups and substantially lower than Melanesians and some African groups. Logistic regression and allele distortion testing revealed no significant associations between the variant and several markers of renal function, as well as blood glucose and blood pressure. These findings suggest that rs773902 is not an important determinant for renal disease in this Indigenous Australian group. However, the relationships between rs773902 genotype and platelet and drug responsiveness in the Tiwi, and the allele frequency in other Indigenous Australian groups should be evaluated.https://www.frontiersin.org/article/10.3389/fgene.2020.00432/fullprotease activated receptor 4rs773902renal diseaseAustralian Aboriginal and Torres Strait Islandersindigenous genetics |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Dian Ningtyas Russell J. Thomson Volga Tarlac Shivashankar H. Nagaraj Shivashankar H. Nagaraj Wendy Hoy John D. Mathews John D. Mathews Simon J. Foote Elizabeth E. Gardiner Justin R. Hamilton Brendan J. McMorran |
spellingShingle |
Dian Ningtyas Russell J. Thomson Volga Tarlac Shivashankar H. Nagaraj Shivashankar H. Nagaraj Wendy Hoy John D. Mathews John D. Mathews Simon J. Foote Elizabeth E. Gardiner Justin R. Hamilton Brendan J. McMorran Analysis of the F2LR3 (PAR4) Single Nucleotide Polymorphism (rs773902) in an Indigenous Australian Population Frontiers in Genetics protease activated receptor 4 rs773902 renal disease Australian Aboriginal and Torres Strait Islanders indigenous genetics |
author_facet |
Dian Ningtyas Russell J. Thomson Volga Tarlac Shivashankar H. Nagaraj Shivashankar H. Nagaraj Wendy Hoy John D. Mathews John D. Mathews Simon J. Foote Elizabeth E. Gardiner Justin R. Hamilton Brendan J. McMorran |
author_sort |
Dian Ningtyas |
title |
Analysis of the F2LR3 (PAR4) Single Nucleotide Polymorphism (rs773902) in an Indigenous Australian Population |
title_short |
Analysis of the F2LR3 (PAR4) Single Nucleotide Polymorphism (rs773902) in an Indigenous Australian Population |
title_full |
Analysis of the F2LR3 (PAR4) Single Nucleotide Polymorphism (rs773902) in an Indigenous Australian Population |
title_fullStr |
Analysis of the F2LR3 (PAR4) Single Nucleotide Polymorphism (rs773902) in an Indigenous Australian Population |
title_full_unstemmed |
Analysis of the F2LR3 (PAR4) Single Nucleotide Polymorphism (rs773902) in an Indigenous Australian Population |
title_sort |
analysis of the f2lr3 (par4) single nucleotide polymorphism (rs773902) in an indigenous australian population |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Genetics |
issn |
1664-8021 |
publishDate |
2020-04-01 |
description |
The F2RL3 gene encoding protease activated receptor 4 (PAR4) contains a single nucleotide variant, rs773902, that is functional. The resulting PAR4 variants, Thr120, and Ala120, are known to differently affect platelet reactivity to thrombin. Significant population differences in the frequency of the allele indicate it may be an important determinant in the ethnic differences that exist in thrombosis and hemostasis, and for patient outcomes to PAR antagonist anti-platelet therapies. Here we determined the frequency of rs773902 in an Indigenous Australian group comprising 467 individuals from the Tiwi Islands. These people experience high rates of renal disease that may be related to platelet and PAR4 function and are potential recipients of PAR-antagonist treatments. The rs773902 minor allele frequency (Thr120) in the Tiwi Islanders was 0.32, which is similar to European and Asian groups and substantially lower than Melanesians and some African groups. Logistic regression and allele distortion testing revealed no significant associations between the variant and several markers of renal function, as well as blood glucose and blood pressure. These findings suggest that rs773902 is not an important determinant for renal disease in this Indigenous Australian group. However, the relationships between rs773902 genotype and platelet and drug responsiveness in the Tiwi, and the allele frequency in other Indigenous Australian groups should be evaluated. |
topic |
protease activated receptor 4 rs773902 renal disease Australian Aboriginal and Torres Strait Islanders indigenous genetics |
url |
https://www.frontiersin.org/article/10.3389/fgene.2020.00432/full |
work_keys_str_mv |
AT dianningtyas analysisofthef2lr3par4singlenucleotidepolymorphismrs773902inanindigenousaustralianpopulation AT russelljthomson analysisofthef2lr3par4singlenucleotidepolymorphismrs773902inanindigenousaustralianpopulation AT volgatarlac analysisofthef2lr3par4singlenucleotidepolymorphismrs773902inanindigenousaustralianpopulation AT shivashankarhnagaraj analysisofthef2lr3par4singlenucleotidepolymorphismrs773902inanindigenousaustralianpopulation AT shivashankarhnagaraj analysisofthef2lr3par4singlenucleotidepolymorphismrs773902inanindigenousaustralianpopulation AT wendyhoy analysisofthef2lr3par4singlenucleotidepolymorphismrs773902inanindigenousaustralianpopulation AT johndmathews analysisofthef2lr3par4singlenucleotidepolymorphismrs773902inanindigenousaustralianpopulation AT johndmathews analysisofthef2lr3par4singlenucleotidepolymorphismrs773902inanindigenousaustralianpopulation AT simonjfoote analysisofthef2lr3par4singlenucleotidepolymorphismrs773902inanindigenousaustralianpopulation AT elizabethegardiner analysisofthef2lr3par4singlenucleotidepolymorphismrs773902inanindigenousaustralianpopulation AT justinrhamilton analysisofthef2lr3par4singlenucleotidepolymorphismrs773902inanindigenousaustralianpopulation AT brendanjmcmorran analysisofthef2lr3par4singlenucleotidepolymorphismrs773902inanindigenousaustralianpopulation |
_version_ |
1724893735337066496 |